Bayes in America
For the first time ever, the annual Bayes 20XX/Bayesian Biostatistics is going to be held outside Europe — in fact we’re going to be in Washington DC.
It will be an unusual edition — the timing is also very different; normally we have the workshop late May/early June. But this year we’ve defered it to late September to more or less fit with other conferences happening at the FDA. We’ve made a big effort in creating stronger links with the regulators (and the Americans, in particular), so this is certainly a great result for our “Founding Father” Bruno Boulanger!
As usual we have several topics of interest, including the following.
The future of the Bayesian Biostatistics in the regulatory world
Clinical Innovative Design
Bayesian biostatistics for Real World Evidence (RWE)
Rare and orphan disease, pediatric development
Meta-analyses, prior elicitation, historical controls, meta-analyses
Reproducibility crisis & related topics such as DoE, Assurance (Success…)
Non-Clinical Statistics, CMC and related topics (QbD, Stability, bioassays, validation, …)
Bayesian inference in complex models (systems biology / PBPK / networks)
Bayesian Spatio-temporal/Temporal modelling (e.g. disease propagation, survival analysis,…)
Bayesian Decision sciences
Benefit/Risk analyses, health economics
Bayesian Big Data, predictive models, selection of variables
Programming and numerical opportunities
Communication of Bayesian statistics
Registrations and call for abstract to open soon!